Blockade of N-methyl-D-aspartate (NMDA) glutamate receptors by MK-801 induces neuronal degeneration in the posterior cingulate/retrosplenial cortex and other corticolimbic regions although damage in the latter has not been adequately characterized. This disseminated corticolimbic damage is of interest since NMDA hypofunction, the mechanism that triggers this neurodegenerative syndrome, has been postulated to play a role in the pathophysiology of Alzheimer's disease (AD). Several histological methods, including electron microscopy, were used to evaluate the neurotoxic changes in various corticolimbic regions of rat brain following MK-801 or a combination of MK-801 plus pilocarpine. We found that MK-801 triggers neuronal degeneration in a widespread pattern similar to that induced by phencyclidine and that females showed more damage than males. The neurotoxic reaction involved additional brain regions when muscarinic receptors were hyperactivated by administering pilocarpine with MK-801. Ultrastructural evaluation revealed that a major feature of the neurotoxic action involves degeneration of dendritic spines which entails loss of synaptic complexes. The ultrastructural appearance of degenerating neurons was generally inconsistent with an apoptotic mechanism, although evidence equivocally consistent with apoptosis was observed in some instances. The cell death process evolved relatively slowly and was still ongoing 7 days posttreatment. Relevance of these results to AD is discussed.
INTRODUCTION
Antagonists of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor induce neurotoxic changes in rat brain that vary in severity and distribution depending on the length of time receptor blockade is maintained. Although both competitive and noncompetitive NMDA antagonists induce this neurotoxic syndrome, most studies investigating the syndrome have used the noncompetitive agents phencyclidine (PCP) and MK-801. It was initially shown that a single subcutaneous (sc) treatment with a relatively low dose of either of these agents caused reversible neuronal injury (intracytoplasmic vacuole formation) confined to pyramidal neurons in the posterior cingulate/ retrosplenial cortex (PC/RSC) (Olney et al., 1989) . In addition, low-dose treatment triggered abnormal expression of heat shock protein (HSP-72) in PC/RSC neurons (Sharp et al., 1991; Olney et al., 1991) . It was then shown that a high dose of PCP triggered abnormal HSP-72 expression, not only in the PC/RSC, but also in many other corticolimbic brain regions (Sharp et al., 1992) , that neurons in all of these regions were sometimes killed by a high dose or prolonged dosing regimens of PCP (Ellison & Switzer, 1993; Ellison, 1994; Corso et al., 1997) and that adding a low dose of pilocarpine to a high dose of PCP increased the frequency with which the widespread cell-killing effect could be produced (Corso et al., 1997) .
It is not clear whether MK-801 reproduces the widespread cell-killing action of PCP. Sharp et al. 
